Invivyd (IVVD) Stock Price

Invivyd Price

NASDAQ·CLOSED
0.62
​
Market closed

For Invivyd, the net margin of -98.2% is up versus -669.4% a few years ago. The consensus 12-month price target for Invivyd is 1.53 USD, about 147.2% above where the stock trades today. Of 9 analysts, 1 rate the stock a buy — an overall Sell consensus.

Invivyd stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Invivyd business model & stock analysis

Invivyd Inc, listed under ticker IVVD with ISIN US00534A1025, is a biotechnology company based in Waltham, Massachusetts, operating within the Health Care sector. The company went public via an IPO on August 6, 2021, and currently employs 122 full-time staff. Invivyd focuses on the discovery, development, and commercialization of antibody-based solutions targeting infectious diseases with pandemic potential. Its technology integrates evolutionary virology, predictive modeling, and antibody engineering to identify antibodies with a high barrier to viral escape. The company's pipeline includes antibody candidates for the prevention and treatment of infectious diseases, particularly emphasizing SARS-CoV-2 (COVID-19). One notable candidate, VYD222, is a monoclonal antibody engineered from adintrevimab (ADG20), demonstrating in vitro neutralizing activity against dominant SARS-CoV-2 variants, including XBB.1.5. VYD222 was designed to provide neutralizing protection across multiple variants of concern. Invivyd aims to deliver antibody-based therapies that protect vulnerable populations from the severe impacts of viral threats. The company's website is https://invivyd.com/, where further information about its research and development efforts can be found. Invivyd's work centers on addressing global health challenges through innovative biotechnological approaches, focusing on rapid response to emerging viral threats.

Frequently asked questions about Invivyd

9 analysts currently rate the Invivyd stock: 8 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Invivyd to generate revenue of 60.05 M USD and earnings per share of -0.86 USD.

Converted at the current exchange rate, the Invivyd share trades at 0.55 EUR (0.62 USD).

The Invivyd share (IVVD) is listed on 1 stock exchanges, including: NASDAQ (ADGI).

The expected revenue of Invivyd is 60.05 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Invivyd is -148.52 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Invivyd is currently -0.72. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Invivyd stock.

The price-to-sales ratio (P/S) of Invivyd is currently 1.78. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Invivyd stock.

The Eulerpool Quality Score for Invivyd is 2/10.

The ISIN of Invivyd is US00534A1025. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Invivyd is IVVD. The ticker symbol is used to trade Invivyd shares on the stock exchange.

Fair ValueTerminal
0.52 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Biotechnology
Number of shares
Employees
Revenue per Employee
437,918.03 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website invivyd.com
Currency
USD
Initial public offering
Aug 6, 2021
ISIN
US00534A1025
Cusip
00534A102
Market capitalization
174.55 M USDMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
-0.72
P/Ee 2027
-1.16
P/Ee 2028
-2.42
P/Ee 2029
1.40
P/Ee 2030
0.83
P/S
P/Se
1.78
EV/EBIT
0.91
P/B Ratio
0.72
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-21.61 %
Last updated Oct 19, 2026, 8:16 PM

Invivyd Peer Group

Invivyd Ticker

NASDAQ · ADGI

Invivyd FIGI

IVVD:US · BBG00W4ML039IVVD:UA · BBG011VMQF65IVVD:UC · BBG011VMQF74IVVD:UN · BBG011VMQF92IVVD:UP · BBG011VMQFB9IVVD:UQ · BBG011VMQFC8IVVD:UB · BBG011VMQFD7IVVD:UM · BBG011VMQFG4IVVD:UX · BBG011VMQFH3IVVD:UD · BBG011VMQFN6IVVD:UF · BBG011VMQFR2IVVD:VY · BBG011VMQFS1

All fundamentals and in-depth analysis of Invivyd

Our stock analysis for Invivyd stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Invivyd. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.